HomeCompareRSLBF vs MCD

RSLBF vs MCD: Dividend Comparison 2026

RSLBF yields 1.37% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCD wins by $56.9K in total portfolio value· pulled ahead in Year 2
10 years
RSLBF
RSLBF
● Live price
1.37%
Share price
$23.00
Annual div
$0.31
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.6K
Annual income
$149.57
Full RSLBF calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — RSLBF vs MCD

📍 MCD pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRSLBFMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RSLBF + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RSLBF pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RSLBF
Annual income on $10K today (after 15% tax)
$116.34/yr
After 10yr DRIP, annual income (after tax)
$127.13/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, MCD beats the other by $22,166.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RSLBF + MCD for your $10,000?

RSLBF: 50%MCD: 50%
100% MCD50/50100% RSLBF
Portfolio after 10yr
$50.1K
Annual income
$13,188.63/yr
Blended yield
26.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

RSLBF
No analyst data
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RSLBF buys
0
MCD buys
0
No recent congressional trades found for RSLBF or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRSLBFMCD
Forward yield1.37%2.35%
Annual dividend / share$0.31$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3%
Portfolio after 10y$21.6K$78.5K
Annual income after 10y$149.57$26,227.70
Total dividends collected$1.4K$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: RSLBF vs MCD ($10,000, DRIP)

YearRSLBF PortfolioRSLBF Income/yrMCD PortfolioMCD Income/yrGap
1$10,837$136.87$10,815$334.85+$22.00RSLBF
2← crossover$11,734$138.62$11,826$491.71$92.00MCD
3$12,696$140.28$13,123$730.06$427.00MCD
4$13,726$141.84$14,853$1,100.07$1.1KMCD
5$14,830$143.33$17,257$1,690.61$2.4KMCD
6$16,013$144.72$20,752$2,667.01$4.7KMCD
7$17,280$146.04$26,103$4,354.83$8.8KMCD
8$18,637$147.29$34,794$7,437.78$16.2KMCD
9$20,090$148.46$49,926$13,461.60$29.8KMCD
10$21,646$149.57$78,550$26,227.70$56.9KMCD

RSLBF vs MCD: Complete Analysis 2026

RSLBFStock

RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.

Full RSLBF Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this RSLBF vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RSLBF vs SCHDRSLBF vs JEPIRSLBF vs ORSLBF vs KORSLBF vs MAINRSLBF vs YUMRSLBF vs QSRRSLBF vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.